Alpha1-antitrypsin Deficiency Registry
NCT00005292 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-03-25
Summary
To collect data from the 37 participating clinical centers on patients with alpha1-antitrypsin deficiency, including those who received replacement therapy with an intravenous preparation of alpha1-proteinase inhibitor (A1Pi) concentrate.
Conditions
- Lung Diseases
- Emphysema
- Alpha-1 Antitrypsin Deficiency
- Chronic Obstructive Pulmonary Disease
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Mark Schluchter · The Cleveland Clinic
Eligibility
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1988-09-30
- Completion
- 1999-11-30
More Related Trials
-
Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction
NCT07152834 ·Status: RECRUITING
-
Pulmonary Care and Research Collaborative Patient Registry
NCT05445817 ·Status: UNKNOWN
-
Prevalence of Alpha-1 Antitrypsin Dysfunction in Pulmonary Emphysema
NCT02382367 ·Status: COMPLETED ·Phase: NA
-
A National Registry For Pulmonary Alveolar Proteinosis
NCT02461615 ·Status: RECRUITING
-
Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
NCT00212511 ·Status: WITHDRAWN
-
Functional and Structural Lung Imaging in Chronic Obstructive Pulmonary Disease
NCT04966221 ·Status: UNKNOWN
-
Genomic Research in Alpha-1 Antitrypsin Deficiency
NCT01832220 ·Status: COMPLETED
-
Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
NCT04664192 ·Status: RECRUITING
-
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
NCT02315586 ·Status: COMPLETED
-
Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function
NCT05582798 ·Status: COMPLETED ·Phase: PHASE4
-
Czech AATD Registry
NCT05178277 ·Status: RECRUITING
-
Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency
NCT03008915 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation and Treatment of Patients With Lung Disease Not Participating in Research
NCT00001621 ·Status: COMPLETED
-
Investigating Idiopathic Pulmonary Fibrosis in Greece
NCT03074149 ·Status: COMPLETED
-
Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease
NCT02055222 ·Status: COMPLETED
-
Pulmonary Fibrosis Foundation Patient Registry
NCT02758808 ·Status: COMPLETED
-
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02058602 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Causes and Disease Processes of Chronic Lung Disease
NCT00001183 ·Status: COMPLETED
-
Pulmonary Hypertension Biorepository and Registry
NCT04808596 ·Status: RECRUITING
-
Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases
NCT00005317 ·Status: COMPLETED
-
Early Risk Predictors For Chronic Pulmonary Disease
NCT00005281 ·Status: COMPLETED
-
Inflammation, Autonomic Dysfunction and Airway Disease
NCT00005298 ·Status: COMPLETED
-
Analyzing Lung Tissue in People With and Without Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung Transplantation
NCT00756522 ·Status: COMPLETED
-
Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency
NCT02547532 ·Status: COMPLETED
-
Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung Disease
NCT00820729 ·Status: COMPLETED